| |
| |
|
| Insider
Information: |
Morrell Martha |
| Relationship: |
Chief Medical Officer |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
90,262 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$737,441 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,262 |
|
|
| Total
Value |
$737,441 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neuropace Inc |
NPCE |
Chief Medical Officer |
2024-02-27 |
90,262 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
90,262 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-02-05 |
4 |
AS |
$15.17 |
$52,278 |
D/D |
(3,446) |
77,762 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-02-02 |
4 |
AS |
$15.07 |
$213,122 |
D/D |
(14,143) |
81,208 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-02-01 |
4 |
AS |
$15.04 |
$9,971 |
D/D |
(663) |
95,351 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-01-31 |
4 |
AS |
$15.08 |
$28,990 |
D/D |
(1,923) |
96,014 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-01-30 |
4 |
AS |
$15.10 |
$170,004 |
D/D |
(11,262) |
97,937 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-01-25 |
4 |
AS |
$15.00 |
$15 |
D/D |
(1) |
109,199 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2024-01-24 |
4 |
AS |
$15.03 |
$12,426 |
D/D |
(827) |
109,200 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2023-12-27 |
4 |
AS |
$10.12 |
$134,648 |
D/D |
(13,300) |
110,027 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2023-12-26 |
4 |
AS |
$10.00 |
$1,020 |
D/D |
(102) |
123,327 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2023-12-20 |
4 |
AS |
$10.14 |
$27,695 |
D/D |
(2,730) |
123,429 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2023-12-06 |
4 |
AS |
$8.16 |
$89,773 |
D/D |
(11,005) |
126,159 |
0 |
% |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2023-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
137,164 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2022-10-07 |
4 |
OE |
$0.03 |
$15 |
D/D |
576 |
57,164 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
46,760 |
56,588 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical officer |
• – – |
2021-06-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,310 |
9,828 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical officer |
• – – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,181 |
9,699 |
0 |
- |
|
| NPCE |
Neuropace Inc |
Chief Medical officerOfficer |
• – – |
2021-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,518 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
